Pfizer
Ticker > Company >

Pfizer share price

Pfizer Ltd.

NSE: PFIZER BSE: 500680 SECTOR: Pharmaceuticals & Drugs  132k   434   54

4669.95
-342.45 (-6.83%)
NSE: 20 Dec 04:02 PM

Price Summary

Today's High

₹ 5055.5

Today's Low

₹ 4601

52 Week High

₹ 6451.15

52 Week Low

₹ 3950

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 21363.96 Cr.

Enterprise Value

₹ 19319.75 Cr.

No. of Shares

4.57 Cr.

P/E

34.58

P/B

5.7

Face Value

₹ 10

Div. Yield

0.75 %

Book Value (TTM)

₹  819.9

CASH

₹ 2046.71 Cr.

DEBT

₹ 2.5 Cr.

Promoter Holding

63.92 %

EPS (TTM)

₹  135.07

Sales Growth

-9.55%

ROE

16.21 %

ROCE

22.37%

Profit Growth

-11.64 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Pfizer Ltd.

Becosules Folvite VIAGRA COREX LS RABEPRAZOLE GELUSIL BRONCOVIT WYSOLONE ANACIN Zavicefta Zinforo Meronem Magnex Zosyn

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-9.55%
3 Year-0.68%
5 Year1.05%

Profit Growth

1 Year-11.64%
3 Year3.48%
5 Year5.14%

ROE%

1 Year16.21%
3 Year20.02%
5 Year18.63%

ROCE %

1 Year22.37%
3 Year26.57%
5 Year24.74%

Debt/Equity

0.0007

Price to Cash Flow

83.18

Interest Cover Ratio

49.3519

CFO/PAT (5 Yr. Avg.)

0.726450675598305

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 63.92 0.00
Jun 2024 63.92 0.00
Mar 2024 63.92 0.00
Dec 2023 63.92 0.00
Sep 2023 63.92 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 20.021117205743% over the past 3 years.
  • Company has been maintaining healthy ROCE of 26.5718751557418% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 49.3519.
  • The Company has been maintaining an effective average operating margins of 29.6512514044038% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -2.02359999999999 days.
  • Company has a healthy liquidity position with current ratio of 5.0092.
  • The company has a high promoter holding of 63.92%.

 Limitations

  • The company has shown a poor profit growth of 3.47628821388695% for the Past 3 years.
  • The company has shown a poor revenue growth of -0.680346565822421% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 575.21 539.97 546.63 562.86 588.59
Total Expenditure 392.6 387.42 357.2 385.37 399.34
Operating Profit 182.61 152.55 189.43 177.49 189.25
Other Income 36.07 35.85 75.13 41.84 43.07
Interest 2.73 2.86 6.95 2.11 2.1
Depreciation 15.43 17.55 13.75 14.6 14.99
Exceptional Items 0 7.95 0 0 0
Profit Before Tax 200.52 175.94 243.86 202.62 215.23
Tax 51.56 45.96 65 51.91 56.88
Profit After Tax 148.96 129.98 178.86 150.71 158.35
Adjusted EPS (Rs) 32.56 28.41 39.1 32.94 34.61

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 2151.65 2238.55 2610.99 2424.76 2193.17
Total Expenditure 1578.93 1526.15 1775.05 1615.81 1557.85
Operating Profit 572.72 712.4 835.94 808.95 635.32
Other Income 184.02 81.12 62.65 101.05 180.51
Interest 11.01 15.39 10.7 13.48 15.43
Depreciation 103.24 109.41 115 105.51 62.28
Exceptional Items 0 0 0 33 7.95
Profit Before Tax 642.49 668.72 772.89 824.01 746.07
Tax 133.36 171.11 160.33 200.08 194.74
Net Profit 509.13 497.61 612.56 623.93 551.33
Adjusted EPS (Rs.) 111.29 108.77 133.89 136.38 120.51

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 45.75 45.75 45.75 45.75 45.75
Total Reserves 3349.74 2347.29 2818.66 3161.55 3549.79
Borrowings 0 0 0 0 0
Other N/C liabilities 135.93 85.06 136.23 38.41 32.74
Current liabilities 873.36 774.34 852.89 657.35 546.56
Total Liabilities 4404.78 3252.44 3853.53 3903.06 4174.84
Assets
Net Block 941.91 864.74 840.96 749.25 712.71
Capital WIP 0.76 2.76 1.15 7.93 0.4
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 255.26 291.62 549.2 550.26 589.78
Other N/C Assets 193.78 220.02 100.78 102.28 134.14
Current Assets 3013.07 1873.3 2361.44 2493.34 2737.81
Total Assets 4404.78 3252.44 3853.53 3903.06 4174.84
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 642.49 668.72 772.89 824.01 746.07
Adjustment -53.56 54.53 76.17 -131.26 -89.32
Changes in Assets & Liabilities -52.46 -91.78 43.94 -34.49 -246.09
Tax Paid -213.29 -204.14 -225.92 -302.58 -153.82
Operating Cash Flow 323.18 427.33 667.08 355.68 256.84
Investing Cash Flow 1530.32 -468.84 -575.02 -36.05 53.7
Financing Cash Flow -163.52 -1571.07 -180.51 -345.79 -235.14
Net Cash Flow 1689.98 -1612.58 -88.45 -26.16 75.4

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 63.92 63.92 63.92 63.92 63.92
john wyeth & brother ltd 1.93 1.93 1.93 1.93 1.93
parke, davis & company ll... 2.09 2.09 2.09 2.09 2.09
pfizer east india b v 39.75 39.75 39.75 39.75 39.75
pharmacia corporation 1.71 1.71 1.71 1.71 1.71
warner-lambert company ll... 2.60 2.60 2.60 2.60 2.60
wyeth holdings corporatio... - - - - 3.56
wyeth llc 12.28 12.28 12.28 12.28 12.28
wyeth holdings corporatio... 3.56 3.56 3.56 3.56 -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 36.08 36.08 36.08 36.08 36.08
atul limited 2.10 - 2.10 2.10 2.10
investor education and pr... - 0.88 0.88 - 0.88
life insurance corporatio... 5.79 5.79 5.79 5.79 4.31
nippon life india trustee... - - - 3.73 3.76
quant mutual fund - quant... - - - - 2.08
sbi magnum midcap fund - - - - 1.31
investor education and pr... 0.89 - - 0.88 -
nippon life india trustee... - - 3.75 - -
uti nifty midcap 150 qual... - - 1.02 - -
nippon life india trustee... 3.74 3.85 - - -
aditya birla sun life tru... 1.65 - - - -

Company News

Pfizer informs about issuance of duplicate share certificates 11 Dec, 4:47 PM Pfizer - Quaterly Results 28 Oct, 6:05 PM Pfizer - Quaterly Results 28 Oct, 6:05 PM Pfizer - Quaterly Results 28 Oct, 6:05 PM Pfizer informs about newspaper publication 8 Aug, 4:58 PM Pfizer - Quaterly Results 29 Jul, 7:47 PM Pfizer - Quaterly Results 29 Jul, 7:47 PM Pfizer informs about annual secretarial compliance report 27 May, 4:31 PM Pfizer - Quaterly Results 17 May, 7:41 PM Pfizer - Quaterly Results 17 May, 7:41 PM Pfizer - Quaterly Results 9 Feb, 2:40 PM Pfizer - Quaterly Results 9 Feb, 2:40 PM Pfizer - Quaterly Results 9 Feb, 2:40 PM Pfizer informs about appointment of executive director 22 Jan, 9:41 AM Pfizer - Quaterly Results 28 Oct, 3:26 PM Pfizer - Quaterly Results 28 Oct, 3:26 PM Pfizer - Quaterly Results 28 Oct, 3:26 PM Pfizer informs about change in management 18 Aug, 4:44 PM Pfizer - Quaterly Results 11 Aug, 4:29 PM Pfizer - Quaterly Results 11 Aug, 4:29 PM Pfizer - Quaterly Results 11 Aug, 4:29 PM Pfizer informs about loss of share certificates 20 Jul, 4:56 PM Pfizer informs about loss of share certificates 20 Jun, 11:15 AM Pfizer reports marginal rise in Q4 net profit 16 May, 10:09 AM Pfizer - Quaterly Results 15 May, 5:53 PM Pfizer - Quaterly Results 15 May, 5:53 PM Pfizer informs about loss of share certificate 20 Apr, 5:03 PM Pfizer informs about issue of duplicate certificate 28 Mar, 2:46 PM Pfizer to acquire Seagen for $43 billion 14 Mar, 2:07 PM Pfizer transfers Thane business undertaking to Vidhi Research and Development 27 Feb, 10:29 AM Pfizer informs about outcome of board meeting 9 Feb, 5:21 PM Pfizer - Quaterly Results 9 Feb, 4:42 PM Pfizer - Quaterly Results 9 Feb, 4:42 PM Pfizer - Quaterly Results 9 Feb, 4:42 PM Pfizer - Quaterly Results 11 Nov, 4:15 PM Pfizer - Quaterly Results 11 Nov, 4:15 PM Pfizer - Quaterly Results 11 Nov, 4:15 PM Pfizer informs about board meeting 1 Sep, 5:24 PM Pfizer informs about unaudited financial results 5 Aug, 4:24 PM Pfizer - Quaterly Results 5 Aug, 3:10 PM Pfizer - Quaterly Results 5 Aug, 3:10 PM Pfizer - Quaterly Results 5 Aug, 3:10 PM Pfizer transfers Upjohn business to Mylan Pharmaceuticals for Rs 180.48 crore 2 Aug, 11:43 AM Pfizer - Quaterly Results 20 May, 7:38 PM Pfizer - Quaterly Results 20 May, 7:38 PM Pfizer informs about disclosure 29 Apr, 10:26 AM Pfizer - Quaterly Results 3 Feb, 4:36 PM Pfizer - Quaterly Results 3 Feb, 4:36 PM Pfizer - Quaterly Results 3 Feb, 4:36 PM Pfizer informs about closure of trading window 31 Dec, 4:18 PM

Pfizer Stock Price Analysis and Quick Research Report. Is Pfizer an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Pfizer and its performance over the period of time. Pfizer stock price today is Rs 4669.95.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Pfizer cash from the operating activity was Rs 256.84 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Pfizer has a Debt to Equity ratio of 0.0007 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Pfizer , the EPS growth was -11.6359 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Pfizer has OPM of 28.9681146468354 % which is a good sign for profitability.
     
  • ROE: Pfizer have a average ROE of 16.2088 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Pfizer is Rs 4669.95. One can use valuation calculators of ticker to know if Pfizer share price is undervalued or overvalued.
Last Updated on:
Brief about Pfizer

Pfizer Ltd Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

 

Pfizer Ltd. is a leading pharmaceutical company that has been operating in India for more than fifty years. The company is renowned for its high-quality products, innovative research, and reliable customer service.  We will focus on the various parameters that long-term stock investors should consider while analyzing the company's stock.

Pfizer Ltd  Share Price

The share price of Pfizer Ltd. is a critical parameter that investors should constantly monitor while analyzing the stock. Pfizer Ltd. is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). Investors can regularly track the share price of the company through our trading platform.

Pfizer Ltd Balance Sheet

The balance sheet of Pfizer Ltd. provides valuable insights into the company's financial health and overall stability. For long-term investors considering investing in the company's stock, analyzing the balance sheet is pivotal. At Ticker, investors can refer to the company's balance sheets and utilize our pre-built screening tools to calculate fair value using DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis.

Pfizer Ltd  Annual Report

The annual report of Pfizer Ltd. provides detailed information about the company's strategies, performance, and achievements for the preceding year. Long-term investors should carefully study these reports to gain insights into the company's business model, growth trajectory, and future plans. Ticker offers easy access to these annual reports, and they are available as downloadable resources for investors' convenience.

Pfizer Ltd  Dividend

Companies distribute dividends as a return on shareholders' investments. Pfizer Ltd. is a reputable company that values its shareholders and regularly distributes dividends. Investors can explore the company's dividend history and stay updated on the latest dividend announcements through our platform.

Pfizer Ltd  Quarterly Results

Investors should analyze the quarterly results of Pfizer Ltd. to evaluate the company's financial performance over specific periods. Ticker offers comprehensive tools and resources to facilitate this analysis. Investors can access quarterly reports, use analytical tools, and employ pre-built screening tools to assess the company's growth trends, profitability, and overall financial stability.

Pfizer Ltd Stock Price

Monitoring stock prices is essential for investors looking to buy or sell shares of Pfizer Ltd. Ticker platform provides real-time stock price data, ensuring that investors have access to the latest market information to make informed decisions. Investors can closely track the stock's fluctuations, historical trends, and trading volumes to evaluate the stock's performance.

Pfizer Ltd Price Chart

Price charts provide graphical representations of a stock's historical price movements, helping investors identify patterns and trends. Ticker offers comprehensive price charts of Pfizer Ltd.'s stock, enabling investors to visualize the stock's performance over time.

Pfizer Ltd News

Staying up-to-date with the latest news about Pfizer Ltd. is critical for long-term investors. Our platform provides easy access to current news, including market changes, corporate announcements, industry developments, and other relevant events that may impact the stock market. Investors can access these news updates to stay informed and make informed investment decisions.

Pfizer Ltd Concall Transcripts

Conference call transcripts provide valuable insights into Pfizer Ltd.'s management discussions regarding financial results, operational strategies, and future plans. By offering access to concall transcripts, our platform ensures that investors have first-hand information about the company's direction and future prospects.

Pfizer Ltd  Investor Presentations

Pfizer Ltd. presents its corporate strategies, financial performance, and future projections through investor presentations. These presentations offer a glimpse into the company's growth plans, market positioning, and operational strategies. Ticker provides an avenue to download these presentations, enabling investors to make well-informed decisions based on a comprehensive understanding of the company's objectives.

Pfizer Ltd  Promoters

Promoters are individuals or entities responsible for starting the company, raising capital, and maintaining management control. Understanding the vision, strategies, and plans of Pfizer Ltd.'s promoters is integral to evaluating the company's investment potential. Investors can access this information and relevant data about the promoters through our platform.

Pfizer Ltd  Shareholders

Identifying the major shareholders of Pfizer Ltd. along with their respective stakes and voting power is crucial for assessing the company's governance structure and overall stability. Our platform furnishes shareholders' data, offering investors insights into the company's ownership structure.

Pfizer Ltd ROCE

Pfizer Ltd ROCE (Return on Capital Employed) is a critical financial ratio used to assess the company's profitability in relation to the capital it employs. Investors can find the ROCE data in the financials table or ratio section above, gaining insights into how efficiently Pfizer Ltd generates returns on its capital investments. This ratio provides valuable information about the company's capital efficiency and overall profitability, making it an essential metric for stock analysis.

Pfizer Ltd EBITDA

Pfizer Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a significant financial measure that reflects the company's operational profitability. By excluding non-operating expenses, the EBITDA data available in the financials table or ratio section above provides insights into Pfizer Ltd's core business performance and operational efficiency.

Pfizer Ltd DPS

Pfizer Ltd DPS (Dividends Per Share) represents the cash distributed to shareholders for each share held in the company. Investors can evaluate Pfizer Ltd's dividend policy and potential returns by referring to the DPS data available in the financials table or ratio section above. This metric is particularly important for those seeking regular income from their investments.

Pfizer Ltd EPS

Pfizer Ltd EPS (Earnings Per Share) is a fundamental metric indicating the company's profitability on a per-share basis. By analyzing the EPS data available in the financials table or ratio section above, investors can assess Pfizer Ltd's earning potential and performance. EPS serves as a significant measure for evaluating the value and growth potential of the company's stock.

Read More
X